PAYD Chronic Care Management
Willing Hearts, Helpful Hands
PAYD Chronic Care Management
Chronic Care Management provides primary care that contributes to better health and care for patients with multiple chronic conditions; these conditions include Alzheimer’s and related dementia, arthritis, atrial fibrillation, autism spectrum disorders, cancer, cardiovascular disease, chronic obstructive pulmonary disease, depression, diabetes, hypertension, infectious diseases such as HIV/AIDS, and other chronic conditions. Patients have access to the providers 24-hours-a-day, 7-days-a-week, and this service includes face to face visits as well as communication by phone, tele-visit (video call) and email.
A comprehensive care plan is developed, which includes a your health issues, goals, providers, medications, and other services you have or may need. It also explains the care you need and how your care will be coordinated. Your health care provider will ask you to sign an agreement to provide this service. Transitional care management will also be provided in the event of an emergency room visit, hospitalization, or other facility discharge. Your health care provider will ask you to sign an agreement to provide this service.
Chronic Care Management may help a patient have reduced pain, increased mobility, and better sleep. Ideally, patients receiving chronic care management will be able to return to some of the activities that they used to do before, and achieve a better quality of life with the help of continuous management of their chronic conditions.
Want to learn more? Click here for more details on Chronic Care Management from Medicare.
Opportunities to Participate in Clinical Research Study
While Alzheimer’s disease can be devastating to patients, families, and their caregivers, clinical trials are looking at new ways to fight this disease and are great opportunities to participate and make a difference.
Hope Through Research
The Rethink-ALZ trial is now open to qualifying participants. The trials last for 52 weeks. If you enroll into this trial, you will receive either the oral study drug or placebo twice a day. A placebo looks like the study drug but has no impact on the person taking it. There is no cost to the patient to participate in the Rethink-ALZ trial or for any of the study-related procedures. No hospitalization is required. If you or a loved one are interested in participating in one of these studies, the following criteria must be met:
- Be ages 50 to 87 years old.
- Be diagnosed with, or have a suspected clinical diagnosis of, Alzheimer’s disease.
- Have a gradual change in memory for six months or more.
- Have a family member or loved one who can be available as a study partner during the entire study.
- Be fully vaccinated for COVID-19 or have had a previous COVID-19 infection.
Other criteria will apply.
Paving a Better Future
Agitation associated with Alzheimer’s dementia can be difficult to manage and can be very challenging for patients and their loved ones. The ASPECTTM clinical research study is evaluating an investigational drug for agitation associated with Alzheimer’s dementia and participants are needed. Participants will not have to pay for the study drug (the investigational drug or placebo), study supplies, study visits, or study tests. Health insurance is not required. To be eligible, participants must:
- Be between the ages of 50 and 90.
- Have a diagnosis of probable Alzheimer’s dementia.
- Have moderate-to-severe agitation that interferes with their daily life.
- Have a reliable caregiver who is able to comply with all study procedures
.Other criteria will apply.